Prenetics Spends $11 Million To Buy 100 Bitcoin T

Prenetics Global Limited (NASDAQ: PRE) announced the purchase of 100 bitcoin at an average price of $109,594, expanding its total holdings to 378 BTC — valued at roughly $41 million. 

The move comes just days after the health sciences company completed a $44 million equity offering that was oversubscribed by strategic investors including Kraken, Exodus, GPTX by Jihan Wu, XtalPi, DL Holdings, and tennis champion Aryna Sabalenka.

“This 100 Bitcoin acquisition demonstrates our immediate execution on the strategic vision we outlined to investors,” said CEO Danny Yeung, highlighting Prenetics’ dual focus on scaling its wellness brand IM8 and building long-term value through bitcoin accumulation.

Following the acquisition and equity raise, Prenetics holds $127 million in total liquidity with no debt—$86 million in cash and $41 million in bitcoin. The company continues to purchase one bitcoin per day, supplementing that with opportunistic larger buys.

Yeung noted that IM8 has reached $100 million in annual recurring revenue in just 11 months, calling it the fastest growth in the supplement industry’s history. Prenetics aims to expand IM8 globally while strengthening its bitcoin treasury as a core balance sheet asset.

Prenetics as a Bitcoin treasury company

For context, Prenetics made headlines earlier this year by becoming the first healthcare firm to implement a Bitcoin treasury strategy. The company initially purchased $20 million worth of BTC, acquiring 187.42 coins at an average price of $106,712, with plans to allocate the majority of its $117 million balance sheet to Bitcoin.

Since then, Prenetics has executed a disciplined accumulation plan, purchasing roughly one bitcoin per day since August 1, 2025, and now holds about 275 BTC, valued at $31 million as of late October. 

The strategy is part of a broader effort to combine its fast-growing supplement brand, IM8 — which reached $100 million ARR in under a year — with long-term cryptocurrency holdings.

The company has also strengthened its leadership and advisory team, appointing former OKEx COO Andy Cheung to the board and engaging industry experts from Kraken and TOKEN2049. 

The firm’s dual focus on health supplements and Bitcoin accumulation underscores its ambition to reach $1 billion in annual revenue alongside $1 billion in Bitcoin holdings over the next five years, highlighting the growing intersection of healthcare and cryptocurrency innovation.

Back in 2024, former footballer David Beckham became a strategic investor in Prenetics and co-founded IM8, citing his focus on advanced consumer health products. 

Beckham also engaged with shareholder Professor Dennis Lo, learning about his pioneering prenatal testing work and early cancer detection focus, reinforcing the potential impact of Prenetics’ innovations on global health.